| Chapter 541 |
| 2016 -- S 2294 SUBSTITUTE A Enacted 09/26/2016 |
| A N A C T |
| RELATING TO INSURANCE -- DRUG COVERAGE |
| Introduced By: Senators Crowley, Sosnowski, Metts, and Miller |
| Date Introduced: February 09, 2016 |
| It is enacted by the General Assembly as follows: |
| SECTION 1. Section 27-18-50 of the General Laws in Chapter 27-18 entitled "Accident |
| and Sickness Insurance Policies" is hereby amended to read as follows: |
| 27-18-50. Drug coverage. -- (a) Any accident and sickness insurer that utilizes a |
| formulary of medications for which coverage is provided under an individual or group-plan, |
| master contract shall require any physician or other person authorized by the department of health |
| to prescribe medication to prescribe from the formulary. A physician or other person authorized |
| by the department of health to prescribe medication shall be allowed to prescribe medications |
| previously on, or not on, the accident and sickness insurer's formulary if he or she believes that |
| the prescription of the non-formulary medication is medically necessary. An accident and |
| sickness insurer shall be required to provide coverage for a non-formulary medication only when |
| the non-formulary medication meets the accident and sickness insurer's medical-exception criteria |
| for the coverage of that medication. |
| (b) An accident and sickness insurer's medical exception criteria for the coverage of non- |
| formulary medications shall be developed in accordance with § 23-17.13-3(c)(3). |
| (c) Any subscriber who is aggrieved by a denial of benefits to be provided under this |
| section may appeal the denial in accordance with the rules and regulations promulgated by the |
| department of health pursuant to chapter 17.12 of title 23. |
| (d) Prior to removing a prescription drug from its plan's formulary or making any change |
| in the preferred or tiered, cost-sharing status of a covered prescription drug, an accident and |
| sickness insurer must provide at least thirty (30) days' notice to authorized prescribers by |
| established communication methods of policy and program updates and by updating available |
| references on web-based publications. All affected members must be provided at least thirty (30) |
| days' notice prior to the date such change becomes effective by a direct notification: |
| (i) The written or electronic notice must contain the following information: |
| (A) The name of the affected prescription drug; |
| (B) Whether the plan is removing the prescription drug from the formulary, or changing |
| its preferred or tiered, cost-sharing status; and |
| (C) The means by which subscribers may obtain a coverage determination or medical |
| exception, in the case of drugs that will require prior authorization or are formulary exclusions |
| respectively. |
| (ii) An accident and sickness insurer may immediately remove from its plan formularies |
| covered prescription drugs deemed unsafe by the accident and sickness insurer or the Food and |
| Drug Administration, or removed from the market by their manufacturer, without meeting the |
| requirements of this section. |
| (d)(e) This section shall not apply to insurance coverage providing benefits for: (1) |
| hospital confinement indemnity; (2) disability income; (3) accident only; (4) long-term care; (5) |
| Medicare supplement; (6) limited-benefit health; (7) specified-disease indemnity; (8) sickness or |
| bodily injury or death by accident or both; or (9) other limited-benefit policies. |
| SECTION 2. Section 27-19-42 of the General Laws in Chapter 27-19 entitled "Nonprofit |
| Hospital Service Corporations" is hereby amended to read as follows: |
| 27-19-42. Drug coverage. -- (a) Any nonprofit, hospital-service corporation that utilizes |
| a formulary of medications for which coverage is provided under an individual or group-plan, |
| master contract shall require any physician or other person authorized by the department of health |
| to prescribe medication to prescribe from the formulary. A physician or other person authorized |
| by the department of health to prescribe medication shall be allowed to prescribe medications |
| previously on, or not on, the nonprofit, hospital-service corporation's formulary if he or she |
| believes that the prescription of the non-formulary medication is medically necessary. A |
| nonprofit hospital service corporation shall be required to provide coverage for a non-formulary |
| medication only when the non-formulary medication meets the nonprofit, hospital-service |
| corporation's medical-exception criteria for the coverage of that medication. |
| (b) A nonprofit, hospital-service corporation's medical-exception criteria for the |
| coverage of non-formulary medications shall be developed in accordance with § 23-17.13- |
| 3(c)(3). |
| (c) Any subscriber who is aggrieved by a denial of benefits to be provided under this |
| section may appeal the denial in accordance with the rules and regulations promulgated by the |
| department of health pursuant to chapter 17.12 of title 23. |
| (d) Prior to removing a prescription drug from its plan's formulary or making any change |
| in the preferred or tiered cost-sharing status of a covered prescription drug, a nonprofit, hospital- |
| service corporation must provide at least thirty (30) days' notice to authorized prescribers by |
| established communication methods of policy and program updates and by updating available |
| references on web-based publications. All affected members must be provided at least thirty (30) |
| days' notice prior to the date such change becomes effective by a direct notification: |
| (i) The written or electronic notice must contain the following information: |
| (A) The name of the affected prescription drug; |
| (B) Whether the plan is removing the prescription drug from the formulary, or changing |
| its preferred or tiered, cost-sharing status; and |
| (C) The means by which subscribers may obtain a coverage determination or medical |
| exception, in the case of drugs that will require prior authorization or are formulary exclusions |
| respectively. |
| (ii) A nonprofit, hospital-service corporation may immediately remove from its plan |
| formularies covered prescription drugs deemed unsafe by the nonprofit, hospital-service |
| corporation or the Food and Drug Administration, or removed from the market by their |
| manufacturer, without meeting the requirements of this section. |
| SECTION 3. Section 27-20-37 of the General Laws in Chapter 27-20 entitled "Nonprofit, |
| Medical-Service Corporations" is hereby amended to read as follows: |
| 27-20-37. Drug coverage. -- (a) Any nonprofit, medical-service corporation that utilizes |
| a formulary of medications for which coverage is provided under an individual or group-plan, |
| master contract shall require any physician or other person authorized by the department of health |
| to prescribe medication to prescribe from the formulary. A physician or other person authorized |
| by the department of health to prescribe medication shall be allowed to prescribe medications |
| previously on, or not on, the nonprofit, medical-service corporation's formulary if he or she |
| believes that the prescription of the non-formulary medication is medically necessary. A |
| nonprofit, hospital-service corporation shall be required to provide coverage for a non-formulary |
| medication only when the non-formulary medication meets the nonprofit, medical-service |
| corporation's medical-exception criteria for the coverage of that medication. |
| (b) A nonprofit, medical-service corporation's medical-exception criteria for the |
| coverage of non-formulary medications shall be developed in accordance with § 23-17.13- |
| 3(c)(3). |
| (c) Any subscriber who is aggrieved by a denial of benefits to be provided under this |
| section may appeal the denial in accordance with the rules and regulations promulgated by the |
| department of health pursuant to chapter 17.12 of title 23. |
| (d) Prior to removing a prescription drug from its plan's formulary or making any change |
| in the preferred or tiered, cost-sharing status of a covered prescription drug, a nonprofit, medical- |
| service corporation must provide at least thirty (30) days' notice to authorized prescribers by |
| established communication methods of policy and program updates and by updating available |
| references on web-based publications. All affected members must be provided at least thirty (30) |
| days' notice prior to the date such change becomes effective by a direct notification: |
| (i) The written or electronic notice must contain the following information: |
| (A) The name of the affected prescription drug; |
| (B) Whether the plan is removing the prescription drug from the formulary, or changing |
| its preferred or tiered, cost-sharing status; and |
| (C) The means by which subscribers may obtain a coverage determination or medical |
| exception, in the case of drugs that will require prior authorization or are formulary exclusions |
| respectively. |
| (ii) A nonprofit, medical-service corporation may immediately remove from its plan |
| formularies covered prescription drugs deemed unsafe by the nonprofit, medical-service |
| corporation or the Food and Drug Administration, or removed from the market by their |
| manufacturer, without meeting the requirements of this section. |
| SECTION 4. Section 27-20.1-15 of the General Laws in Chapter 27-20.1 entitled |
| "Nonprofit Dental Service Corporations" is hereby amended to read as follows: |
| 27-20.1-15. Drug coverage. -- (a) Any nonprofit, dental-service corporation that utilizes |
| a formulary of medications for which coverage is provided under an individual or group-plan, |
| master contract shall require any physician or other person authorized by the department of health |
| to prescribe medication to prescribe from the formulary. A physician or other person authorized |
| by the department of health to prescribe medication shall be allowed to prescribe medications |
| previously on, or not on, the nonprofit, dental-service corporation's formulary if he or she |
| believes that the prescription of the non-formulary medication is medically necessary. A |
| nonprofit, dental-service corporation shall be required to provide coverage for a non-formulary |
| medication only when the non-formulary medication meets the nonprofit, dental-service |
| corporation's medical exception criteria for the coverage of that medication. |
| (b) A nonprofit, dental-service corporation's medical-exception criteria for the coverage |
| of non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3). |
| (c) Any subscriber who is aggrieved by a denial of benefits to be provided under this |
| section may appeal the denial in accordance with the rules and regulations promulgated by the |
| department of health pursuant to chapter 17.12 of title 23. |
| (d) Prior to removing a prescription drug from its plan's formulary or making any change |
| in the preferred or tiered, cost-sharing status of a covered prescription drug, a nonprofit, dental- |
| service corporation must provide at least thirty (30) days' notice to authorized prescribers by |
| established communication methods of policy and program updates and by updating available |
| references on web-based publications. All affected members must be provided at least thirty (30) |
| days' notice prior to the date such change becomes effective by a direct notification: |
| (i) The written or electronic notice must contain the following information: |
| (A) The name of the affected prescription drug; |
| (B) Whether the plan is removing the prescription drug from the formulary, or changing |
| its preferred or tiered, cost-sharing status; and |
| (C) The means by which subscribers may obtain a coverage determination or medical |
| exception, in the case of drugs that will require prior authorization or are formulary exclusions |
| respectively. |
| (ii) A nonprofit, dental-service corporation may immediately remove from its plan |
| formularies covered prescription drugs deemed unsafe by the nonprofit, dental-service |
| corporation or the Food and Drug Administration, or removed from the market by their |
| manufacturer, without meeting the requirements of this section. |
| SECTION 5. Section 27-41-51 of the General Laws in Chapter 27-41 entitled "Health |
| Maintenance Organizations" is hereby amended to read as follows: |
| 27-41-51. Drug coverage. -- (a) Any health-maintenance organization that utilizes a |
| formulary of medications for which coverage is provided under an individual or group-plan, |
| master contract shall require any physician or other person authorized by the department of health |
| to prescribe medication to prescribe from the formulary. A physician or other person authorized |
| by the department of health to prescribe medication shall be allowed to prescribe medications |
| previously on, or not on, the health-maintenance organization's formulary if he or she believes |
| that the prescription of non-formulary medication is medically necessary. A health-maintenance |
| organization shall be required to provide coverage for a non-formulary medication only when the |
| non-formulary medication meets the health-maintenance organization's medical exception criteria |
| for the coverage of that medication. |
| (b) A health-maintenance organization's medical-exception criteria for the coverage of |
| non-formulary medications shall be developed in accordance with § 23-17.13-3(c)(3). |
| (c) Any subscriber who is aggrieved by a denial of benefits to be provided under this |
| section may appeal the denial in accordance with the rules and regulations promulgated by the |
| department of health pursuant to chapter 17.12 of title 23. |
| (d) Prior to removing a prescription drug from its plan's formulary or making any change |
| in the preferred or tiered, cost-sharing status of a covered prescription drug, a health-maintenance |
| organization must provide at least thirty (30) days' notice to authorized prescribers by established |
| communication methods of policy and program updates and by updating available references on |
| web-based publications. All affected members must be provided at least thirty (30) days' notice |
| prior to the date such change becomes effective by a direct notification: |
| (i) The written or electronic notice must contain the following information: |
| (A) The name of the affected prescription drug; |
| (B) Whether the plan is removing the prescription drug from the formulary, or changing |
| its preferred or tiered, cost-sharing status; and |
| (C) The means by which subscribers may obtain a coverage determination or medical |
| exception, in the case of drugs that will require prior authorization or are formulary exclusions |
| respectively. |
| (ii) A health-maintenance organization may immediately remove from its plan |
| formularies covered prescription drugs deemed unsafe by the health-maintenance organization or |
| the Food and Drug Administration, or removed from the market by their manufacturer, without |
| meeting the requirements of this section. |
| SECTION 6. This act shall take effect on January 1, 2017. |
| ======== |
| LC003117/SUB A |
| ======== |